High interest rates pose significant challenges to REITs (Real Estate Investment Trusts). However, this challenging environment also presents a unique opportunity to invest before the anticipated shift in interest rate policy by the Federal Reserve (FED). The reasoning is simple: as interest rates decline, the borrowing costs for REITs will decrease, making them more attractive to investors.
For instance, I’ve been eyeing a specific REIT, Realty Income ($O), for over a year now. But before diving into Realty Income, let's first discuss why REITs, in general, are worth considering right now.
Why REITs?
REITs are companies that own, operate, or finance income-generating real estate. Instead of purchasing property directly, investors can buy shares in a REIT, which in turn owns and manages a portfolio of real estate assets. This approach allows investors to earn dividends from the rental income without the headaches of property management. Moreover, REITs are legally required to return 90% of their taxable income to shareholders as dividends, often resulting in attractive yields.
It seems like tokenizing real estate.
Until early 2023, REITs consistently outperformed the S&P 500. However, as the S&P 500 surged, REITs began to lag. Yet, in the last six months, this trend has started to reverse. The real estate sector has grown by 8.7% over the past six months, compared to a 6.3% increase in the S&P 500. This shift is largely due to expectations surrounding interest rates.
High interest rates make REITs less attractive because these companies rely on borrowing to finance growth. Higher rates mean higher interest expenses, which can squeeze profit margins and slow expansion. But with inflation now approaching the FED’s target, a reduction in rates seems imminent, possibly as soon as the next FED meeting on September 18th. Lower borrowing costs will make REITs more profitable and, therefore, more attractive to investors.
Why Realty Income ($O)?
(Look at the volume)
What makes Realty Income so appealing is its outstanding management. The company manages 15,500 properties with an average occupancy rate near 100%. Additionally, it’s expanding its operations in Europe, particularly in the UK, where it now manages more properties than in any single U.S. state. Over 25% of its properties are leased to supermarkets and retail chains, providing reliable rental income.
Despite the challenging environment for REITs, Realty Income has delivered consistent growth, with a 22% annual increase in revenue and a 24% increase in Funds from Operations (FFO) over the past year. This growth has been driven by strategic acquisitions, like the recent $9.3 billion purchase of Spirit Realty Capital, adding 2,000 properties to its portfolio, including specialized assets like warehouses and data centers.
Another reason to love Realty Income is its dividend. With a yield exceeding 5.2%, it has consistently increased its dividend for 26 years, earning a spot among the dividend aristocrats. This means monthly payouts you can count on, with the added bonus that earnings per share are growing even faster than the dividend.
https://www.realtyincome.com/sites/realty-income/files/realty-income/quartly-and-annual/2024/2023-annual-report.pdf
Pharma Companies and Test Manufacturers: The Next Big Play?
Switching gears to a different sector, the recent buzz around the Monkeypox (MPOX) outbreak has drawn parallels to the early days of COVID-19. While some fear a new pandemic, there’s a silver lining for investors: companies involved in developing vaccines and diagnostic tests could see significant gains.
For instance, companies like Virax Biolabs ($VRAX) and Applied DNA Sciences ($APDN) have already experienced substantial stock price increases, thanks to their work on diagnostic tests for MPOX. These small-cap companies saw their stock prices soar by 543% and 718%, respectively, in just five days. Just like trading crypto.
Even established companies like Emergent BioSolutions ($EBS), which develops vaccines that can be adapted for MPOX, have seen their stock rise by nearly 150% in the past week. This reaction in the market is entirely rational—investors are drawn to companies directly involved with the outbreak, anticipating increased demand for their products.
While the possibility of a new pandemic has some investors panicking, it's crucial to remain calm. If the situation escalates, we might see market opportunities similar to those during the COVID-19 outbreak—a chance to buy high-quality stocks at depressed prices. For risk-tolerant investors, there’s potential in betting on these smaller companies, though the risk is significant.
Ultimately, whether it’s REITs poised for a comeback as interest rates fall, or pharma and test manufacturers capitalizing on health crises, there are always opportunities if you know where to look. Just remember, investing requires a cool head and a long-term perspective.
